These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 323764)

  • 21. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
    Völker W; Kannengiesser U; Majewski A; Vasterling HW
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
    J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in studies on estrogen biosynthesis.
    Brodie AM
    J Endocrinol Invest; 1979; 2(4):445-60. PubMed ID: 395188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraglandular estrogen production in postmenopausal women with and without endometrial cancer: comparison between "in vitro" and "in vivo" results.
    Jasonni VM; Lodi S; Preti S; Bonavia M; Bulletti C; Bolelli G; Franceschetti F; Flamigni C
    Cancer Detect Prev; 1981; 4(1-4):469-73. PubMed ID: 7349812
    [No Abstract]   [Full Text] [Related]  

  • 25. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma.
    Hausknecht RU; Gusberg SB
    Am J Obstet Gynecol; 1969 Dec; 105(8):1161-7. PubMed ID: 5360244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine studies of normal and polycystic ovarian tissues in vitro.
    Wilson EA; Erickson GF; Zarutski P; Finn AE; Tulchinsky D; Ryan KJ
    Am J Obstet Gynecol; 1979 May; 134(1):56-63. PubMed ID: 220877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of aromatization of exogenous and endogenous androgens in ovaries of hypophysectomized rats in vivo by follicle-stimulating hormone.
    Armstrong DT; Papkoff H
    Endocrinology; 1976 Oct; 99(4):1144-51. PubMed ID: 976193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of estrogen preparations after the menopause and the risk of endometrial carcinoma].
    de Waard F
    Ned Tijdschr Geneeskd; 1976 Jul; 120(29):1263-5. PubMed ID: 934383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary-ovarian relationships in polycystic ovary syndrome.
    Baird DT; Corker CS; Davidson DW; Hunter WM; Michie EA; Van Look PF
    J Clin Endocrinol Metab; 1977 Oct; 45(4):798-801. PubMed ID: 334789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogens and endometrial cancer: aspects of etiology and survival rate.
    Schindler AE
    Arch Geschwulstforsch; 1976; 46(5):345-9. PubMed ID: 1021008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen metabolism in patients at high risk for endometrial carcinoma. II. The role of androstenedione as an estrogen precursor in postmenopausal women with endometrial carcinoma.
    Hausknecht RU; Gusberg SB
    Am J Obstet Gynecol; 1973 Aug; 116(7):981-4. PubMed ID: 4718225
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum estrogens and androgens in women with endometrial carcinoma.
    Pettersson B; Bergström R; Johansson ED
    Gynecol Oncol; 1986 Oct; 25(2):223-33. PubMed ID: 2944804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Risks and benefits of estrogen use.
    Weiss NS
    N Engl J Med; 1975 Dec; 293(23):1200-2. PubMed ID: 1186793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
    Cramer DW; Knapp RC
    Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Oestrogens as a cause of endometrial carcinoma.
    Oakey RE; Hawkins RA
    Br Med J; 1976 May; 1(6017):1071. PubMed ID: 1268555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal bleeding.
    Gambrell RD
    Clin Obstet Gynaecol; 1977 Apr; 4(1):129-43. PubMed ID: 852206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.